24 May 2013
Keywords: corgentech, starts, new, trial, e2f, decoy, usa
Article | 24 May 2004
Corgentech of the USA has initiated a Phase I/II trial of E2F Decoy (edifoligide) for the prevention of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 May 2004
31 May 2004
© 2013 thepharmaletter.com